Professional Documents
Culture Documents
两台迈瑞BS380生化分析仪性能评价结果的比较分析
两台迈瑞BS380生化分析仪性能评价结果的比较分析
两台迈瑞BS380生化分析仪性能
评价结果的比较分析
徐含青1,刘跃平1,2,府伟灵1,黄君富1,魏昆1,杨翔1,黄庆1
1.陆军军医大学第一附属医院 检验科,重庆 400038;2.解放军第477医院 检验科,湖北 襄阳 441003
[摘 要] 目的 比较两台迈瑞BS380配套检测系统的性能评价结果,探讨国产生化分析系统的检测性能及应用中的质量控制。
方法 分别参照EP5-A2、EP9-A2、EP6-A、EP7-A2和我国医药行业标准对两台使用年限在0.2年和3年的迈瑞BS380的16个常
规生化项目进行精密度、方法学比对、分析测量范围、干扰实验和样本针携带污染率评价,并对两台仪器的评价结果进行
比较。结果 两台BS380配套检测系统的方法学比对均未完全通过,虽然通过率差异无统计学意义(P=0.333),但是两台
仪器未通过的项目并不相同;新装机的BS380在精密度、分析测量范围、干扰实验、样本针携带污染率等方面的性能均合
格,而在基层医院使用3年后的BS380检测系统在多个方面的性能出现下滑,总精密度合格率为78.1%、抗干扰宣称符合率
为83.8%、TBIL在宣称分析测量范围内线性欠佳。结论 国产生化分析仪的检测性能已能较好的满足临床需求,但即使是配
套检测系统,为了实现结果的互认也必须进行方法学比对,并对未通过比对的项目进行正确度传递。在仪器使用过程中,
检测性能必须定期进行评价,实时进行监控才可保证结果的有效性。
[关键词] 生化分析仪;性能评价;国产设备;质量控制;结果互认
Abstract: Objective The aim of this study was to compare analytical performances of two Mindray 380 auto biochemistry analyzers
using matching reagents and to discuss analytical performances of domestic biochemistry analyzers and their quality control during
application. Methods Durable years of the two analyzers were 0.2 year (BS380-1) and 3 years (BS380-2), respectively. Precision,
methodological comparison, linearity and interference of 16 common tests and sample needle carryover effects were evaluated
according to CLSI protocols EP5-A2, EP9-A2, EP6-A, EP7-A2 and China’s pharmaceutical industry standard, respectively. Then
results were compared between these two analyzers. Results Results of methodological comparison were not totally passed, though
pass rates were not statistically significant (P=0.333). In addition, tests that were not passed were not the same; BS380-1’s precision,
linearity, interference and sample needle carryover effects all passed while BS380-2’s did not perform well in the aspects of
precision, interference and linearity. Results were as follows: Qualified rates of total precision was 78.1%, coincidence of proposed
anti-interference was 83.8%, and linearity of TBIL was not as good as manufacturer’s statement. Conclusion Domestic analyzer is
suitable for its utilization in modern clinical laboratories. In order to realize results inter-accreditation, methodological comparison
and accuracy transfer are needed even matching reagents are used. Also, periodic evaluation of analytical performances and real-time
monitoring are awaited in order to guarantee effectiveness of results.
Key words: biochemistry analyzer; evaluation of performance; domestic equipment; quality control; results inter-accreditation
[中图分类号] R446.11;TH789 [文献标识码] B
doi:10.3969/j.issn.1674-1633.2018.05.025 [文章编号] 1674-1633(2018)05-0093-04
引言 规划和协调发展,从此,医疗器械产业迈入大发展时期。随
自 1987 年国务院先后批转国家计委和国家经委下发的 着我国医疗器械市场的发展,国产医疗设备逐渐登上了历史
《关于加速发展医疗器械工业的请示》和《关于发展医疗器 舞台。生化分析仪是作为临床诊疗最基本、最常用的医疗
械工业若干问题的通知》
,提出医疗器械产业的全社会统筹 设备,在我国医疗器械市场发展的浪潮中也脱颖而出。2003
收稿日期:2017-06-14 修回日期:2017-07-19
年,深圳迈瑞研发了我国第一台具有自主知识产权的全自
基金项目:国家科技支撑计划课题(2013BAI17B04)。 动生化分析仪 BS-300[1],随后国产生化分析仪陆续涌出,标
通讯作者:黄庆,主任医师,主要研究方向为分子诊断和设备应
用评价。 示着我国医疗器械攻关技术实现了一项重大突破,打破了
通讯作者邮箱:Dr.Q.huang@gmail.com
表2 方法学比对结果分析表
拟合方程 医学决定水平
仪器
比对通过率 未通过比对项目 比对通过率 未通过比对项目
BS380-1 14/16 (87.5%) CA, DBIL 36/43 (83.7%) TP三个水平, ALB三个水平, CA高值
BS380-2 14/16 (87.5%) HDL-C, CREA 39/43 (90.7%) CREA三个水平, TG低值
上接第 75 页
断中的价值[J].中华放射学杂志,2012,46(6):526-528. [13] Va rg a s H A , D o n a t i O F, Wi b m e r A , e t a l . A s s o c i a t i o n
[6] Mocikova I,Babela J,Balaz V.Prostate cancer-the role of between penile dynamic contrast-enhanced MRI-derived
magnetic resonance imaging[J].Biomed Pap Med Fac Univ quantitative parameters and self-reported sexual function
Palachy Olomouc Czech Repub,2012,156(2):103-107. in patients with newly diagnosed prostate cancer[J].J Sex
[7] Kuhl CK,Schild HH.Dynamic image interpretation of the Med,2014,10(10):2581-2588.
breast[J].JMRI,2000,11:965-974. [14] Rosenkrantz AB,Kim S,Campbell N,et al.Transition zone
[8] Dynamic contrast-enhanced MRI for the detection of prostate prostate cancer: revisiting the role of multiparametric MRI at
cancer: meta-analysis[J].AJR Am J Roentgenol,2015,20(4): 3 T[J].AJR Am J Roentgenol,2015,204(3):266-772.
439-448. [15] Fennessy FM,Fedorov A,Penzkofer T,et al.Quantitative
[9] Barrett T,Davidson SR,Wilson BC,et al.Dynamic contrast pharmacokinetic analysis of prostate cancer DCE-MRI at 3T:
enhanced MRI as a predictor of vascular-targeted photodynamic Comparison of two arterial input functions on cancer detection
focal ablation therapy outcome in prostate cancer post-failed with digized whole mount histopathological validation[J].Magn
external beam radiation therapy[J].Can Urol Assoc J,2014,8(9- Reson Imaging,2015,15(7):47-48.
10):708-714. [16] De Rooij M,Hamoen EH,Futterer JJ,et al.Accuracy of
[10] 王世健,范明,张娟,等.乳腺癌DCE-MRI影像特征与分子分型 multi parametric MRI for prostate cancer detection: a meta-
的关联性研究[J].中国生物医学工程学报,2016,35(5):533-540. analysis[J].AJR Am J Roentgenol,2014,202(2):343-351.
[11] 刘伟,嵇鸣,李若坤,等.MRI鉴别诊断慢性乳腺炎与乳腺癌的 [17] Oto A,Yang C,Kayhan A,et al.Diffusion-weighted and dynamic
价值[J].实用放射学杂志,2016,(2):212-215. contrast-enhanced MRI of prostate cancer: correlation of
[12] Chung MP,Margolis D,Mesko S,et al.Correlation of quantitative quantitative MR parameters with Gleason score and tumor
diffusion-weighted and dynamic contrast-enhanced MRI angiogenesis[J].AJR Am J Roentgenol,2011,197(6):1382-1390.
parameters with prognostic factors in prostate cancer[J].J Med 本文编辑 王静 C
Imaging Radiat Oncol,2014,58(5):588-594.